Weigao Holding Company Limited, often referred to simply as Weigao, is a prominent player in the medical device and pharmaceutical industry, headquartered in China (CN). Founded in 1992, the company has established itself as a leader in the production of high-quality medical consumables, including infusion sets, syringes, and blood collection products, catering to both domestic and international markets. With a strong operational presence across Asia and beyond, Weigao is renowned for its commitment to innovation and quality. The company has achieved significant milestones, including numerous certifications and awards that underscore its market position. Weigao's core products are distinguished by their advanced technology and reliability, making them essential in healthcare settings. As a result, Weigao Holding Company Limited continues to be a trusted name in the medical sector, contributing to improved patient care worldwide.
How does Weigao Holding Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Weigao Holding Company Limited's score of 22 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2020, Weigao Holding Company Limited reported an emission intensity of approximately 0.00004269 kg CO2e per unit of revenue, although specific total emissions figures for Scope 1, 2, and 3 were not disclosed. The previous year, 2019, showed a higher emission intensity of about 0.00009086 kg CO2e per unit of revenue, indicating a potential improvement in their operational efficiency. Currently, Weigao Holding has not set any specific reduction targets or climate pledges, nor do they participate in initiatives such as the Science Based Targets initiative (SBTi). The company operates as a current subsidiary and does not inherit emissions data from a parent organization. Overall, while Weigao Holding Company Limited has made strides in reducing its emission intensity, the lack of comprehensive emissions data and formal climate commitments suggests there is room for further development in their sustainability strategy.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Weigao Holding Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

